Alzheimer's Disease: Clinical and Pathological Characteristics

References

• Abraham C. R., Selkoe D. J., Potter H. Immunochemical identification of the serine protease inhibitor 1/x-antichymotrypsin in the brain amyloid deposits of Alzheimer's Disease. Cell 1988; 52: 487–501
   PubMed Web of Science ®Google Scholar
• Adolfsson R., Fottfries C. G., Roos B. E., Winblad B. Changes in brain catecholamines in patients with dementia of Alzheimer type. British Journal of Psychiatry 1979; 135: 216–223
   PubMedGoogle Scholar
• Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allgemein Zeitschift füir Psychiatrie 1907; 64: 146–148
   Google Scholar
• Appleyard M. E., Smith A. D., Berman P., Wilcock G. K., Esiri M. M., Neary D., Bowen D. M. Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Brain 1987; 110: 1309–1322
   PubMed Web of Science ®Google Scholar
• Arai H., Kosaka K., Izuka R. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer type dementia. Journal of Neurochemistry 1984; 43: 388–393
   PubMed Web of Science ®Google Scholar
• Atack J. P., Bal M. F., May C., Kaye J. A., Mazurek M. F., Kay A. D., Rapoport S. E. Cerebrospinal fluid somatostatin and neuropeptide Y. Archives of Neurology 1988; 45: 269–274
   PubMedGoogle Scholar
• Bird T. D., Lampe T. H., Nemens E. J., Miner G. W., Sumi S. M., Schellenberg G. D. Familial Alzheimer Disease in American descendants of the Volga Germans: Probable genetic founder effect. Annals of Neurology 1988; 23: 25–31
   PubMedGoogle Scholar
• Blessed G., Tomlinson B. E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. British Journal of Psychiatry 1968; 114: 797–811
   PubMed Web of Science ®Google Scholar
• Bowen D. M., Davison A. N. Biochemical studies of nerve cells and energy metabolism in Alzheimer's Disease. British Medical Bulletin 1986; 42: 75–80
   PubMedGoogle Scholar
• Breitner J. C. S. Alzheimer's Disease: Genetic theories of etiology. Handbook of psychopharmacology. Vol 20, Psychopharmacology of the aging nervous syyrem, L. L. Iversen, S. D. Iversen, S. H. Snyder. Plenum Press, New York 1988; 207–235
   Google Scholar
• Breitner J. C. S., Silberman J. M., Mohs R. C., Davis K. L. Familial aggregation in Alzheimer's Disease: A comparison of risk among relatives of early- and late-onset cases, and among male and female relatives in successive generations. Neurology 1988; 38: 207–212
   PubMedGoogle Scholar
• Brown R. G., Marsden C. D. How common is dementia in Parkinson's Disease. Lancet 1984; 2: 1262–1265
   PubMed Web of Science ®Google Scholar
• Castano E. M., Frangione B. Biology of disease human amyloidosis, Alzheimer Disease and related disorders. Laboratory Investigation 1988; 58: 122–132
   PubMed Web of Science ®Google Scholar
• Chu D. C. M., Penney J. B., Young A. B. Quantitative autoradiography of hippocampal GABA, and GABA, receptor changes in Alzheimer's Disease. Neuroscience Letters 1987; 82: 246–252
   PubMed Web of Science ®Google Scholar
• Copeland J. R. M., Kelleher M. J., Kellet J. M. A semistructured clinical interview for the assessment of diagnosis and mental state in the elderly. The geriatric mental state schedule I. Development and reliability. Psychological Medicine 1976; 6: 439–449
   PubMed Web of Science ®Google Scholar
• Cowburn R., Hardy J., Roberts P., Briggs R. Presynaptic and postsynaptic glutaminergic function in Alzheimer's Disease. Neuroscience Letters 1988; 86: 109–113
   PubMed Web of Science ®Google Scholar
• Curcio C. A., Kemper T. Nucleus raphe dorsalis in dementia of the Alzheimer type: Neurofibrillary changes and neuronal packing density. Journal of Neuropathology and Experimental Neurology 1984; 43: 359–368
   PubMed Web of Science ®Google Scholar
• Doebler J. A., Markesbery W. R., Anthony A., Davies P., Scheff S. W., Rhoads R. E. Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's Disease. Annuals of Neurology 1988; 23: 20–24
   PubMedGoogle Scholar
• Drukarch B., Leysen J. E., Stoff J. C. Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4 tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's Disease. Life Sciences 1988; 42: 1011–1018
   PubMedGoogle Scholar
• Erkinjuntti T. Differential diagnosis between Alzheimer's disease and vascular dementia: Evaluation of common clinical methods. Acta Neurologica Scandinavica 1987; 76: 433–442
   PubMedGoogle Scholar
• Erkinjuntti T., Larsen T., Sulkava R., Ketonen L., Laaksonen R., Palo J. EEG in the differential diagnosis between Alzheimer's Disease and vascular dementia. Acta Neurologica Scandinavica 1988; 77: 3844
   Google Scholar
• Fenton W. G. Electrophysiology of Alzheimer's Disease. British Medical Bulletin 1986; 42: 29–33
   PubMed Web of Science ®Google Scholar
• Fitch N., Becker R., Heller A. The inheritance of Alzheimer's Disease: A new interpretation. Annals of Neurology 1988; 23: 14–19
   PubMed Web of Science ®Google Scholar
• Folstein M. F., Folstein S. E., McHugh P. R. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975; 12: 189–198
   PubMed Web of Science ®Google Scholar
• Garruto R. M., Fukatsu R., Yanagihara R., Gajdusek D. C., Hook G., Fiori C. E. Imaging of calcium and aluminum in neurofibrillary tangles of neurons in Parkinsonian-dementia of Guam. Proceedingr of the National Academy of Science of the United States of America 1984; 81: 1875–1879
   PubMed Web of Science ®Google Scholar
• Gasper P., Gray F. Dementia in idiopathic Parkinson's Disease. Acta Neuropathologica 1984; 64: 43–52
   PubMedGoogle Scholar
• Glenner G. G. Alzheimer's Disease: Its proteins and genes. Cell 1988; 52: 307–308
   PubMed Web of Science ®Google Scholar
• Glenner G. G., Wong C. W. Alzheimer's Disease and Down's Syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochemical and Biophysical Research Communications 1984; 122: 1131–1135
   PubMed Web of Science ®Google Scholar
• Gurland B., Kuriansky J., Sharpe L., Simon R., Stiller P., Birkett P. The comprehensive assessment and referral evaluation (CARE). Rationale, development and reliability. International Journal of Aging Human Development 1977; 8: 9–42
   PubMed Web of Science ®Google Scholar
• Hansen L. A., DeTeresa R., Davies P., Terry R. D. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's Disease. Neurology 1988; 38: 48–54
   PubMed Web of Science ®Google Scholar
• Hardy J., Adolfsson R., Alafuzoff I., Bucht G., Marcusson J., Nyberg P., Pendell E., Wester P., Wenblad B. Transmitter deficits in Alzheimer's Disease. Neurochemistry International 1985; 7: 545–563
   PubMed Web of Science ®Google Scholar
• Hersch E. L. Development and application of the extended scale for dementia. Journal of American Geriatric Society 1979; 27: 348–354
   PubMedGoogle Scholar
• Hornqvist R., Henrikson R. Iontophoretic study of adrenergic and cholinergic skin vessel reactivity in normal and Alzheimer's Disease. Gerontology 1987; 33: 374–379
   PubMedGoogle Scholar
• Hoyer S., Oesterreich K., Wagner O. Glucose metabolism as the site of primary abnormality in early-onset dementia of the Alzheimer type. Journal of Neurology 1988; 235: 143–148
   PubMed Web of Science ®Google Scholar
• Hughes C. P., Berg L., Danziger W. L., Coben L. A., Martin R. L. A new clinical scale for the staging of dementia. British Journal of Psychiatry 1982; 140: 566–572
   PubMed Web of Science ®Google Scholar
• Huppert F. A., Tym E. Clinical and neuropsychological assessment of dementia. British Medical Bulletin 1986; 42: 11–18
   PubMed Web of Science ®Google Scholar
• Jesberger J. A., Richardson J. S. Brain output dysregulation induced by olfactory bulbectomy: An approximation in the rat of major depressive disorder in humans. International Journal of Neuroscience 1988; 38: 241–265
   PubMed Web of Science ®Google Scholar
• Kang J., Lemaire H.-G., Uterbeck A., Salbaum J. M., Masters C. L. The precursor of Alzheimer's Disease A4 protein resembles a cell surface receptor. Nature 1987; 325: 733–736
   PubMed Web of Science ®Google Scholar
• Kay D. W. K. The genetics of Alzheimer's Disease. British Medical Bulletin 1986; 42: 19–23
   PubMedGoogle Scholar
• Kellar K. J., Whitehouse P. J., Martino-Barrows A. M., Marcus K., Price D. L. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's Disease cerebral cortex. Brain Research 1987; 436: 62–68
   PubMedGoogle Scholar
• Kidson C., Chen P. DNA damage, DNA repair and the genetic basis of Alzheimer's Disease. Progress in Brain Resarch 1986; 70: 291–301
   PubMedGoogle Scholar
• Kuriansky J. B., Gurland B. J., Fleiss J. L., Cowan D. The assessment of self care capacity in geriatric psychiatric patients by objective and subjective methods. Journal of Clinical Psychology 1986; 32: 95–102
   Google Scholar
• Lawton M. P., Brody E. M. Assessment of older people: Self maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179–186
   PubMed Web of Science ®Google Scholar
• Lewy F. H. Paralysis agitans: Its pathology. Handbook of Neurology 1892; 311–314
   Google Scholar
• Mann D. M. A. Neuropathological and neurochemical aspects of Alzheimer's Disease. Handbook of psychopharmacology. Vol 20, Psycho-pharmacology of the aging nervous system, L. L. Iversen, S. D. Iversen, S. H. Snyder. Plenum Press, New York 1988; 1–67
   Google Scholar
• Mann D.M.A., Tucker C. M., Yates P. O. Alzheimer's Disease: An olfactory connection. Mechanisms of Aging and Development 1988; 42: 1–15
   PubMed Web of Science ®Google Scholar
• Marotta C. A., Majocha R. E., Coughlin J. F., Nanz H. J., Daves P., Ventosa-Michelman M., Chou W. G., Zain S. B., Sajdel-Sulkowska E. M. Transcriptional and translational regulatory mechanisms during normal aging of the mammalian brain and in Alzheimer's Disease. Progress in Brain Research 1986; 42: 24–28
   Google Scholar
• McGeer P. L. Brain imaging in Alzheimer's Disease. British Medical Bulletin 1986; 42: 24–28
   PubMed Web of Science ®Google Scholar
• McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Workgroup under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944
   PubMed Web of Science ®Google Scholar
• McRae-Degueurce A., Booj S., Haglid K., Rosengren L., Karlsson J. E., Karlsson I., Wallin A., Svennerholm L., Gottfies C., Dahlstrom A. Antibodies in cerebrospinal fluid of some Alzheimer Disease patients recognize cholinergic neurons in the rat central nervous system. Proceedings of the National Academy of Science of the United States of America 1987; 84: 9214–9218
   PubMedGoogle Scholar
• Mesulam M. M., Geula C., Moran M. A. Anatomy of cholinesterase inhibition in Alzheimer's Disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Annals of Neurology 1987; 22: 683–691
   PubMedGoogle Scholar
• Morris J. C., Fulling K. Early Alzheimer's Disease diagnostic considerations. Archives of Neurology 1988; 45: 345–349
   PubMedGoogle Scholar
• Mountjoy C. Q. Correlations between neuropathological and neurochemical changes. British Medical Bulletin 1986; 42: 81–85
   PubMed Web of Science ®Google Scholar
• Najlerahim A., Bowen D. M. Regional weight loss of the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type. Acta Neuropathologica 1988; 75: 509–512
   PubMed Web of Science ®Google Scholar
• Nordberg A., Adem A., Hardy J., Winblad B. Change in nicotinic receptor subtypes in the temportal cortex of Alzheimer brains. Neuroscience letters 1988; 86: 317–321
   PubMed Web of Science ®Google Scholar
• Pattie A. H., Gilleard C. J. A brief psychogeriatric assessment schedule. Validation against psychiatric diagnosis and discharge from hospital. British Journal of Psychiatry 1975; 127: 489–493
   PubMed Web of Science ®Google Scholar
• Penn R. D., Martin E. M., Wilson R. S., Fox J. H., Savoy S. M. Intracentricular bethanechol infusion for Alzheimer's Disease: Results of double-blind and escalating-dose trials. Neurology 1988; 38: 219–222
   PubMed Web of Science ®Google Scholar
• Perl D. P., Brody A. R. Alzheimer's Disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle bearing neurons. Science 1980; 208: 297–298
   PubMed Web of Science ®Google Scholar
• Perry E. K. The cholinergic hypothesis—ten years on. British Medical Bulletin 1986; 42: 63–69
   PubMed Web of Science ®Google Scholar
• Perry R. H. Recent advances in neuropathology. British. Medical Bulletin 1986; 42: 34–41
   PubMed Web of Science ®Google Scholar
• Perry R. H., Tomlinson B. E., Candy J. M., Blessed G., Foster J. F., Bloxham C. A., Perry E. R. Cortical cholinergic deficit in mentally impaired Parkinsonian patients. Lancet 1983; 2: 789–790
   PubMed Web of Science ®Google Scholar
• Polinsky R. J., Nobel H., Dichiro G., Nee L. E., Feldman R. G., Brown R. T. Dominantly inherited Alzheimer's Disease: Cerebral glucose metabolism. Journal of Neurology, Neurosurgery and Psychiatry 1987; 50: 752–757
   PubMedGoogle Scholar
• Proctor A. W., Palmer A. M., Francis P. T., Lowe S. L., Neary D., Murphy E., Doshi R., Bowen D. M. Evidence of glutaminergic denervation and possible abnormal metabolism in Alzheimer's Disease. Journal of Neurochemistry 1988; 50: 790–802
   PubMedGoogle Scholar
• Quinn N. P., Rossor M. N., Marsden C. Dementia and Parkinson's Disease—Pathological and neurochemical considerations. British Medical Bulletin 1986; 42: 86–90
   PubMed Web of Science ®Google Scholar
• Reinikainen K. J., Riekkinen P. J., Paljarvi L., Soininen H., Helkala E. L., Jolkkonen J., Laakso M. Cholinergic deficit in Alzheimer's Disease: A study based on CSF and autopsy data. Neurochemrcal Research 1988; 13: 135–146
   PubMed Web of Science ®Google Scholar
• Reisberg B., Ferris S. H., DeLeon M. J., Crook T. The global deterioration scale of assessment of primary degenerative dementia. American Journal of Psychiatry 1982; 139: 1136–1139
   PubMed Web of Science ®Google Scholar
• Robins L. N., Helzer J. E., Croughan J., Ratcliffe K. S. National Institute of Mental Health Diagnostic Interview Schedule Its history, characteristics and validity. Archives of General Psychiatry 1981; 38: 381–389
   PubMed Web of Science ®Google Scholar
• Robinson R. A. Some problems of clinical trials in elderly people. Gerontologica Clinica 1961; 3: 247–257
   PubMedGoogle Scholar
• Rodgers J. D., Brogan D., Mirra S. S. The nucleus basalis of Meynert in neurological disease: A quantitative morphological study. Annals of Neurology 1985; 17: 163–170
   PubMedGoogle Scholar
• Rosen W. G., Hohs R. C., Davis K. L. A new rating scale for Alzheimer's Disease. American Journal of Psychiatry 1984; 141: 1356–1364
   PubMed Web of Science ®Google Scholar
• Rossor M. Neurochemical studies in dementia. Handbook of psychopharmacology. Vol 20, Psychopharmacology of the aging nervous system, L. L. Iversen, S. D. Iversen, S. H. Snyder. Plenum Press, New York 1988; 107–130
   Google Scholar
• Rossor M., Iversen L. L. Non-cholinergic neurotransmitter abnormalities in Alzheimer's Disease. British Medical Bulletin 1986; 42: 70–74
   PubMed Web of Science ®Google Scholar
• Roth M. The association of clinical and neurological findings and its bearing on the classification and etiology of Alzheimer's Disease. British Medical Bulletin 1986; 42: 42–50
   PubMed Web of Science ®Google Scholar
• Roth M., Tym E., Mountjoy C. Q., Huppert F. A., Hendrie H., Verma S., Goddard R. CAMDEX: A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry 1986; 249: 698–709
   Google Scholar
• Sarter M., Bodwitz G., Stephens D. N. Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology (Berlin) 1988; 94: 491–495
   PubMed Web of Science ®Google Scholar
• Clair D., St., Blackburn I., Blackwood D., Tyrer G. Measuring the course of Alzheimer's Disease. A longitudinal study of the neuropsychological function and changes in P3 event-related potential. British Journal of Psychiatry 1988; 152: 48–54
   PubMedGoogle Scholar
• Tanzi R. E., Gusella J. F., Watkins P. C., Bruns G. A. P., George-Hyslop P., St., Van Keuren M. L., Patterson D., Pagan S., Kurnit D. M., Neve R. L. Amyloid 8-protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science 1987; 235: 880–885
   PubMed Web of Science ®Google Scholar
• Tomlinson B. E., Blessed G., Roth M. Observations on the brains of non-demented old people. Journal of Neurological Science 1968; 7: 331–356
   PubMed Web of Science ®Google Scholar
• Tomlinson B. E., Corsellis J. A. N. Aging and the dementias. Greenfield's neuropathology, A. J. Hume, N.A.J. Corsellis, L. W. Duchken. Edward Arnold, London 1984; 951–1025
   Google Scholar
• Tierney M. C., Fisher R. H., Lewis A. J., Zorzitto M. L., Snow W. G., Reid D. W., Nieuwstrate P. The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's Disease: A clinicopathological study of 57 cases. Neurology 1988; 38: 359–364
   PubMed Web of Science ®Google Scholar
• Whalley L. J. The dementia of Down's Syndrome and its relevance to aetiological studies of Alzheimer's Disease. Annals of the New York Academy of Science 1982; 369: 39–53
   Google Scholar
• Whitehouse P. J. Intraventricular bethanechol in Alzheimer's Disease: A continuing controversy. Neurology 1988; 38: 307–308
   PubMedGoogle Scholar
• Wilcock G. K., Esiri M. M., Bowen D. M., Smith C. C. T. The nucleus basalis in Alzheimer's Disease: Cell counts and cortical biochemistry. Neuropathology and Applied Neurobiology 1983; 9: 175–179
   PubMed Web of Science ®Google Scholar
• William A. F., Sharpe J. A. Smooth pursuit dysfunction in Alzheimer's Disease. Neurology 1988; 38: 212–711
   Google Scholar
• Wilson B., Cockburn J., Baddeley A. D. The Rivermead Behavioral Memory Test. Thames Valley Test Company, Reading, Berks 1985
   Google Scholar
• Wisniewski K. E., Wisniewski H. M., Wen G. Y. Occurrence of neuropathological changes and dementia of Alzheimer's Disease in Down's Syndrome. Annals of Neurology 1985; 17: 278–282
   PubMed Web of Science ®Google Scholar
• Yatham L. N., McHale P. A., Kinsella A. Down's Syndrome and its association with Alzheimer's Disease. Acta Psychiatrica Scandinavica 1988; 77: 38–39
   PubMedGoogle Scholar
• Zubenko G. S., Moossy J., Hanin I., Martinez J., Rao G. R., Kopp U. Bilateral symmetry of cholinergic deficits in Alzheimer's Disease. Archives of Neurology 1988; 45: 255–259
   PubMed Web of Science ®Google Scholar